rethinkTHC Search
Menu
Study breakdown

Review of health risks and organ damage from synthetic cannabinoids

Narrative ReviewModerate evidence
The takeaway

Synthetic cannabinoids can damage the brain, heart, kidneys, and liver through CB1/CB2 receptor activation and non-cannabinoid targets, producing effects far more dangerous than natural cannabis.

Emergency medicine providers, people exposed to synthetic cannabinoids, public health officials

Multi-organ toxicity via CB1, CB2, and beyond

What the researchers found

Synthetic cannabinoids produce multisystem toxicity through CB1R and CB2R activation plus non-cannabinoid targets (GPR55, GPR18, PPARs, TRPV1). Downstream effects include oxidative stress, inflammation, and apoptosis in neurological, cardiovascular, renal, and hepatic systems.

Why it matters

Synthetic cannabinoids remain widely available despite bans and cause disproportionate emergency department visits relative to their use rates. Understanding multi-organ toxicity mechanisms helps clinicians recognize and treat exposures.

The numbers in context

SC toxicity mediated by CB1R, CB2R, and non-cannabinoid targets including GPR55, GPR18, PPARs, and TRPV1. Effects documented across neurological, cardiovascular, renal, and hepatic systems.

How the study worked

Narrative review of published literature on synthetic cannabinoid health effects, organized by organ system and molecular mechanism of toxicity.

What this study cannot tell us

Review-level evidence with heterogeneous case reports and preclinical studies. Many synthetic cannabinoid variants exist with different toxicity profiles. Dose-response relationships are poorly characterized.

How to read the evidence

Comprehensive review synthesizing case reports and preclinical data, but limited by heterogeneous evidence quality.

When this study was published

2024 review of synthetic cannabinoid toxicity literature

The bigger picture

While natural cannabis primarily activates CB1 as a partial agonist, many synthetic cannabinoids are full agonists with much higher potency and affinity. This pharmacological difference explains why synthetic cannabinoids produce emergency presentations rarely seen with natural cannabis.

Questions still open

  • Can clinicians distinguish synthetic cannabinoid toxicity from natural cannabis effects in emergency settings? Are there effective antidotes for acute synthetic cannabinoid poisoning?

Common questions

Why are synthetic cannabinoids more dangerous than natural cannabis?
Many synthetic cannabinoids are full agonists at CB1 receptors with much higher potency than THC, which is only a partial agonist. They also activate non-cannabinoid targets. This produces more severe effects across multiple organ systems.
What organs can synthetic cannabinoids damage?
The review documented toxicity across neurological (seizures, psychosis, stroke), cardiovascular (arrhythmias, myocardial infarction), renal (acute kidney injury), and hepatic (liver damage) systems.

Read the original research

The synthetic cannabinoids menace: a review of health risks and toxicity.

European journal of medical research, 29(1), 49

Citation

Alzu'bi, Ayman; Almahasneh, Fatimah; Khasawneh, Ramada; Abu-El-Rub, Ejlal; Baker, Worood Bani; Al-Zoubi, Raed M. (2024). The synthetic cannabinoids menace: a review of health risks and toxicity.. European journal of medical research, 29(1), 49. https://doi.org/10.1186/s40001-023-01443-6

Explore the wider topic